Professor of Pediatrics
Department of Pediatrics
Stanford School of Medicine

Division of Medical Genetics
Lucile Salter Packard Children's Hospital
300 Pasteur Drive, Boswell Building A097
Stanford, CA 94304
contact address


Dr. Stevenson graduated from the University of Utah School of Medicine, completed Pediatric residency at the University of New Mexico, and a Medical Genetics Fellowship at the University of Utah, where he joined the faculty in 2005. In 2015, Dr. Stevenson joined the Division of Medical Genetics at Stanford School of Medicine. He is board-certified in Pediatrics and Medical Genetics.

Dr. Stevenson’s clinical interests include disorders of the Ras/MAPK pathway (e.g., NF1, Noonan syndrome, Costello syndrome, CFC syndrome), vascular anomalies, and bone disorders. He attends at the Osteogenesis Imperfecta Clinic at the Salt Lake City Shriners Hospital and the Hereditary Hemorrhagic Telangiectasia (HHT) Clinic at the University of Utah. His research focuses on the pathophysiology of the musculoskeletal abnormalities of the Rasopathies, with a primary focus on scoliosis and tibial dysplasia in NF1. He also conducts research on Prader-Willi syndrome, vascular malformations, and the genetics of non-syndromic orthopedic manifestations such as developmental dysplasia of the hip.

Dr. Stevenson has written more than 120 scientific papers in peer reviewed journals and several book chapters. He serves on the National Prader-Willi Syndrome Association Scientific Advisory Board, the Costello Syndrome Family Support Network Professional Advisory Committee, the Cardiofaciocutaneous syndrome International Medical Advisory Board, and the Children’s Tumor Foundation Bone Abnormalities Consortium, and medical advisory boards for Costello syndrome and cardiofaciocutaneous syndrome support groups.

Dr. Stevenson has been the Principal Investigator or Co-Investigator of grants from the National Institutes of Health, the Department of Defense, Shriner Research Foundation, American Academy of Otolaryngology, Thrasher Research Fund, March of Dimes, and Doris Duke Charitable Foundation.

No conflicts of interest (09/21/2022)

Selected Bibliography:

Margraf RL, VanSant-Webb C, Sant D, Carey J, Hanson H, D'Astous J, Viskochil D, Stevenson DA, Mao R.
Utilization of Whole-Exome Next-Generation Sequencing Variant Read Frequency for Detection of Lesion-Specific, Somatic Loss of Heterozygosity in a Neurofibromatosis Type 1 Cohort with Tibial Pseudarthrosis.
J Mol Diagn. 2017;19(3):468-474. PubMed abstract / Full Text

Johnson BA, Sheng X, Perry AS, Stevenson DA.
Activity and participation in children with neurofibromatosis type 1.
Res Dev Disabil. 2014;36C:213-221. PubMed abstract

Stevenson DA, Yang FC.
The musculoskeletal phenotype of the RASopathies.
Am J Med Genet C Semin Med Genet. 2011;157C(2):90-103. PubMed abstract

Muram TM, Stevenson DA, Watts-Justice S, Viskochil DH, Carey JC, Mao R, Jackson B.
A cost savings approach to SPRED1 mutational analysis in individuals at risk for neurofibromatosis type 1.
Am J Med Genet A. 2013;161(3):467-72. PubMed abstract

Stevenson DA, Little D, Armstrong L, Crawford AH, Eastwood D, Friedman JM, Greggi T, Gutierrez G, Hunter-Schaedle K, Kendler DL, Kolanczyk M, Monsell F, Oetgen M, Richards BS, Schindeler A, Schorry EK, Wilkes D, Viskochil DH, Yang FC, Elefteriou F.
Approaches to treating NF1 tibial pseudarthrosis: consensus from the Children's Tumor Foundation NF1 Bone Abnormalities Consortium.
J Pediatr Orthop. 2013;33(3):269-75. PubMed abstract